MX2009008964A - Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento. - Google Patents
Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento.Info
- Publication number
- MX2009008964A MX2009008964A MX2009008964A MX2009008964A MX2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A
- Authority
- MX
- Mexico
- Prior art keywords
- ageing
- vitro
- genotyping
- applications
- product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La invención se refiere a un método "in vitro" para determinar el riesgo genético global de un sujeto a desarrollar una patología asociada al envejecimiento. Dicho método, se basa en la combinación de riesgos genéticos particulares a desarrollar patologías comunes asociadas al envejecimiento. Dichos riesgos genéticos particulares se determinan a partir de los resultados obtenidos del genotipado simultáneo de determinadas variaciones genéticas asociadas a dichas patologías asociadas al envejecimiento y, cuyo principal objetivo, es su uso en medicina anti-envejecimiento.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200700493 | 2007-02-23 | ||
PCT/ES2008/000094 WO2008102038A2 (es) | 2007-02-23 | 2008-02-21 | Método y producto para genotipado “in vitro” con aplicación en medicina anti-envejecimiento |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009008964A true MX2009008964A (es) | 2009-12-01 |
Family
ID=39710568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008964A MX2009008964A (es) | 2007-02-23 | 2008-02-21 | Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110045997A1 (es) |
EP (1) | EP2128275A4 (es) |
AU (1) | AU2008217662A1 (es) |
CA (1) | CA2679014A1 (es) |
CO (1) | CO6231055A2 (es) |
MX (1) | MX2009008964A (es) |
WO (1) | WO2008102038A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010146214A2 (es) * | 2009-06-17 | 2010-12-23 | Progenika Biopharma, S.A. | Método para la evaluación del comportamiento atlético de un sujeto |
JP2013162783A (ja) * | 2012-01-10 | 2013-08-22 | Arkray Inc | Pon1遺伝子多型(q192r)を検出する方法 |
US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
JP2019136000A (ja) * | 2018-02-13 | 2019-08-22 | 国立大学法人金沢大学 | 冠動脈疾患の罹患リスクの判定方法又は判定の補助方法 |
CN108841966A (zh) * | 2018-06-12 | 2018-11-20 | 广州中安基因科技有限公司 | 一种瘦身基因检测试剂盒 |
CN109355368A (zh) * | 2018-10-22 | 2019-02-19 | 江苏美因康生物科技有限公司 | 一种快速检测高血压个体化用药基因多态性的试剂盒及方法 |
CN111212069B (zh) * | 2019-12-31 | 2022-02-25 | 重庆邮电大学 | 一种5g功能开放设备接口的脆弱性评估方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU782102B2 (en) * | 1999-08-12 | 2005-07-07 | Wisconsin Alumni Research Foundation | Identification of genetic markers of biological age and metabolism |
US20030036057A1 (en) * | 2001-03-09 | 2003-02-20 | Andreas Braun | Genes and polymorphisms associated with cardiovascular disease and their use |
WO2003035691A1 (en) * | 2001-10-26 | 2003-05-01 | Xenon Genetics, Inc. | Apolipoprotein a-i mutation useful for diagnosis and treatment of cardiovascular diseases |
US20040043389A1 (en) * | 2002-09-04 | 2004-03-04 | Vitivity, Inc. | Methods and compositions for identifying risk factors for abnormal lipid levels and the diseases and disorders associated therewith |
WO2004085996A2 (en) * | 2003-03-20 | 2004-10-07 | Albert Einstein College Of Medicine Of Yeshiva University | Biomarkers for longevity and disease and uses thereof |
US20050191678A1 (en) * | 2004-02-12 | 2005-09-01 | Geneob Usa Inc. | Genetic predictability for acquiring a disease or condition |
EP1566449A1 (en) * | 2004-02-18 | 2005-08-24 | Max-Delbrück-Centrum Für Molekulare Medizin | Use of haplotypes and SNPs in lipid-relevant genes for the analyses and diagnosis of cardiovascular diseases |
US7622271B2 (en) * | 2004-07-26 | 2009-11-24 | University Of Washington | Identification of aging genes through large-scale analysis |
EP1910569A4 (en) * | 2005-06-17 | 2009-08-05 | Genizon Biosciences Inc | GENEMAP GENE CARD OF HUMAN GENES ASSOCIATED WITH LONGEVITY |
US20080233582A1 (en) * | 2005-07-26 | 2008-09-25 | Siemens Healthcare Diagnostics Inc. | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
-
2008
- 2008-02-21 EP EP08736698A patent/EP2128275A4/en not_active Withdrawn
- 2008-02-21 WO PCT/ES2008/000094 patent/WO2008102038A2/es active Application Filing
- 2008-02-21 MX MX2009008964A patent/MX2009008964A/es not_active Application Discontinuation
- 2008-02-21 CA CA002679014A patent/CA2679014A1/en not_active Abandoned
- 2008-02-21 AU AU2008217662A patent/AU2008217662A1/en not_active Abandoned
- 2008-02-21 US US12/528,159 patent/US20110045997A1/en not_active Abandoned
-
2009
- 2009-09-22 CO CO09103198A patent/CO6231055A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20110045997A1 (en) | 2011-02-24 |
AU2008217662A1 (en) | 2008-08-28 |
EP2128275A2 (en) | 2009-12-02 |
EP2128275A4 (en) | 2010-12-08 |
CO6231055A2 (es) | 2010-12-20 |
WO2008102038A3 (es) | 2008-10-09 |
CA2679014A1 (en) | 2008-08-28 |
WO2008102038A2 (es) | 2008-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009008964A (es) | Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento. | |
PH12017501298A1 (en) | Pesticidal compositions and processes related thereto | |
JO3076B1 (ar) | نظم العلاج المناعي المعتمد على حالة apoe | |
PH12015501392A1 (en) | Pesticidal compositions and processes related thereto | |
MX346665B (es) | Composiciones pesticidas y procedimientos relacionados con estas. | |
IL211140A (en) | A method for determining the risk of Alzheimer's disease based on the presence or absence of changes in the tomm40 gene | |
MX355431B (es) | Composiciones plaguicidas y procesos relacionados con dichas composiciones. | |
TW200745217A (en) | Facilitating release of silicone hydrogel ophthalmic lenses | |
ECSP099833A (es) | Anticuerpos humanizados contra el globulomero a?(20-42) y sus usos | |
WO2008154352A3 (en) | Genetic markers associated with endometriosis and use thereof | |
ATE505949T1 (de) | Kragen für ein tier | |
DK1999160T3 (da) | Acryleret hyaluronsyre | |
MX2015008065A (es) | Composiciones pesticidas y procesos relacionados con ellas. | |
MX2009003137A (es) | Procesos de latex. | |
MX341178B (es) | Metodos para determinar interacciones de gen-nutriente. | |
WO2014076045A3 (en) | Magnification loupe with display system | |
AU315279S (en) | Pump | |
EP3511422A3 (en) | Methods and compositions for diagnosing, prognosing, and treating endometriosis | |
WO2008112903A3 (en) | Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes | |
MX2010002304A (es) | Metodos para incorporar multiples genes en una planta de cultivo. | |
WO2017041063A3 (en) | Compositions and methods for identifying genetic predisposition to obesity and for enhancing adipogenesis | |
EP3626830A4 (en) | SINGLE NUCLEOTIDE POLYMORPHISM OF AN APOE PROMOTER RELATED TO ALZHEIMER'S MORBUS AND USE OF IT | |
WO2011057125A3 (en) | Compositions and methods for determining cancer susceptibility | |
FR3016888B1 (fr) | Synthetases de la colistine et cluster de genes correspondants | |
MY173473A (en) | Content filtering method and system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: PROGENIKA BIOPHARMA, S.A. |
|
FA | Abandonment or withdrawal |